PROPHASE LABS INC. -

PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024

08 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART

20 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

14 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics

30 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts

23 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024

04 Jan 2024 07:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023

09 Nov 2023 07:00:01 By Nasdaq GlobeNewswire

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

17 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

ProPhase Labs to Present at The ThinkEquity Conference

12 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.

10 Aug 2023 09:40:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023

10 Aug 2023 07:00:02 By Nasdaq GlobeNewswire

ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound

03 Aug 2023 07:00:01 By Nasdaq GlobeNewswire

ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time

02 Aug 2023 07:00:01 By Nasdaq GlobeNewswire

Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea

29 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Inc. Sets the Course for Expansion into the MENA Region with Cutting-Edge Genomic and Diagnostics Technologies

22 Jun 2023 07:30:00 By Nasdaq GlobeNewswire

ProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023

07 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

ProPhase Labs’ Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testing

01 Jun 2023 07:30:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2023

11 May 2023 07:00:02 By Nasdaq GlobeNewswire

ProPhase Labs hires Dr. Matthew Halpert to Drive Company’s Key Therapeutic and Diagnostic Oncology Programs

08 May 2023 07:30:00 By Nasdaq GlobeNewswire